Get Premium to unlock powerful stock data
OTCPK:TSOI (USA)  
Therapeutic Solutions International Inc logo

Therapeutic Solutions International Inc

$ 0.02 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
21.00
Market Cap:
$ 53.45M
Enterprise V:
$ 54.41M
Volume:
1.09M
Avg Vol (2M):
2.98M
Volume:
1.09M
Market Cap $:
53.45M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.98M
Enterprise Value $:
54.41M
PB Ratio:
21.00
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Therapeutic Solutions International Inc
NAICS : 325412 SIC : 2834
701 Wild Rose Lane, Elk City, ID, USA, 83525
Description
Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for development of therapeutics in the area of chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) and Lung Pathology (LP).

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.15
Equity-to-Asset 0.48
Debt-to-Equity 0.49
Debt-to-EBITDA -0.42
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.48
Distress
Grey
Safe
Beneish M-Score -1.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 44.55
9-Day RSI 43.37
14-Day RSI 43.36
6-1 Month Momentum % -19.66
12-1 Month Momentum % -42.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.38
Quick Ratio 0.37
Cash Ratio 0.07
Days Inventory 332.38
Days Sales Outstanding 32.48
Days Payable 2750.7

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.7

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 77.51
Operating Margin % -1229.67
Net Margin % -1614.83
ROA % -181.74
ROIC % -94.82
ROC (Joel Greenblatt) % -849.31

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 21
EV-to-EBIT -20.2
EV-to-EBITDA -20.37
EV-to-Revenue 260.32
Earnings Yield (Greenblatt) % -4.95

Financials

TSOI's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:TSOI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.209
EPS (TTM) ($) -0.001
Beta 2.27
Volatility % 167.23
14-Day RSI 43.36
14-Day ATR ($) 0.00214
20-Day SMA ($) 0.022111
12-1 Month Momentum % -42.18
52-Week Range ($) 0.0168 - 0.1345
Shares Outstanding (Mil) 2,545.36

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Therapeutic Solutions International Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More